FDA Inspection 1116164 — McKesson Corporation dba McKesson Drug Company
The FDA completed an inspection of McKesson Corporation dba McKesson Drug Company on January 16, 2020 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 16, 2020
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Honolulu, HI (United States)